Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know
Lung cancer continues to be one of the leading causes of death worldwide. In advanced cases of lung cancer, a multimodality approach is often applied, however with poor local control rates. In early non-small cell lung cancer (NSCLC), surgery is the standard of care. Only 15-30% of patients are elig...
Main Authors: | Shivank Bhatia, Keith Pereira, Prasoon Mohan, Govindarajan Narayanan, Medhi Wangpaichitr, Niramol Savaraj |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2016-01-01
|
Series: | Indian Journal of Radiology and Imaging |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/0971-3026.178347 |
Similar Items
-
Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
by: Young‐Seok Seo, et al.
Published: (2016-11-01) -
Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
by: J. Palussière, et al.
Published: (2018-08-01) -
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study
by: Yang-Xun Pan, et al.
Published: (2019-08-01) -
Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
by: Yang-Xun Pan, et al.
Published: (2020-10-01) -
Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
by: Zhaonan Li, et al.
Published: (2021-05-01)